Wasatch Advisors LP Has $84.27 Million Stock Holdings in Transcat, Inc. (NASDAQ:TRNS)

Wasatch Advisors LP increased its position in shares of Transcat, Inc. (NASDAQ:TRNS) by 7.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 756,220 shares of the scientific and technical instruments company’s stock after acquiring an additional 55,121 shares during the quarter. Wasatch Advisors LP owned about 8.56% of Transcat worth $84,266,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Diversified Trust Co lifted its stake in shares of Transcat by 4.3% during the fourth quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock valued at $266,000 after acquiring an additional 100 shares during the period. Arizona State Retirement System lifted its stake in Transcat by 11.9% in the fourth quarter. Arizona State Retirement System now owns 2,434 shares of the scientific and technical instruments company’s stock valued at $266,000 after buying an additional 258 shares during the period. Raymond James & Associates lifted its stake in Transcat by 6.5% in the fourth quarter. Raymond James & Associates now owns 6,384 shares of the scientific and technical instruments company’s stock valued at $698,000 after buying an additional 387 shares during the period. Swiss National Bank lifted its stake in Transcat by 2.4% in the fourth quarter. Swiss National Bank now owns 17,215 shares of the scientific and technical instruments company’s stock valued at $1,882,000 after buying an additional 400 shares during the period. Finally, Deutsche Bank AG increased its holdings in shares of Transcat by 13.2% in the third quarter. Deutsche Bank AG now owns 4,405 shares of the scientific and technical instruments company’s stock worth $432,000 after acquiring an additional 512 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Insider Buying and Selling at Transcat

In other Transcat news, Director Charles P. Hadeed sold 1,358 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total value of $176,540.00. Following the completion of the transaction, the director now directly owns 21,320 shares in the company, valued at $2,771,600. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, Director Charles P. Hadeed sold 1,358 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total value of $176,540.00. Following the completion of the sale, the director now directly owns 21,320 shares of the company’s stock, valued at $2,771,600. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider James M. Jenkins sold 5,514 shares of the firm’s stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $137.18, for a total value of $756,410.52. Following the completion of the sale, the insider now directly owns 1,619 shares of the company’s stock, valued at $222,094.42. The disclosure for this sale can be found here. Insiders sold a total of 22,215 shares of company stock worth $2,969,084 over the last ninety days. 4.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Oppenheimer increased their price target on Transcat from $125.00 to $160.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. HC Wainwright increased their price target on Transcat from $124.00 to $156.00 and gave the stock a “buy” rating in a report on Wednesday, May 22nd. Northland Securities downgraded Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 22nd. Finally, Northland Capmk downgraded Transcat from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 22nd. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Transcat presently has a consensus rating of “Hold” and a consensus price target of $142.67.

Transcat Stock Up 4.0 %

Shares of NASDAQ:TRNS traded up $4.76 during mid-day trading on Tuesday, reaching $123.95. 41,782 shares of the stock were exchanged, compared to its average volume of 40,739. The company has a quick ratio of 2.62, a current ratio of 3.14 and a debt-to-equity ratio of 0.01. The company has a market cap of $1.13 billion, a P/E ratio of 77.96 and a beta of 0.68. Transcat, Inc. has a one year low of $81.26 and a one year high of $147.00. The stock’s 50 day simple moving average is $121.70 and its 200-day simple moving average is $111.96.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, May 20th. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.25. The business had revenue of $70.91 million during the quarter, compared to the consensus estimate of $68.76 million. Transcat had a return on equity of 9.50% and a net margin of 5.26%. As a group, equities research analysts predict that Transcat, Inc. will post 1.99 EPS for the current year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.